Summary
Weight loss in patients with atrial fibrillation and a body mass index > 27 kg/m is associated with dose-dependent improved control of sinus rhythm and lower atrial fibrillation burden, according to the 5-year LEGACY study. However, > 5% weight fluctuation can offset these benefits.
- obesity
- atrial fibrillation
- antiarrhythmic drugs
- ablation
- weight loss
- LEGACY
- ACTRN12614001123639
- cardiology & cardiovascular medicine clinical trials
- arrhythmias
- cardiometabolic disorder
- © 2015 SAGE Publications
Tools
Table of contents
Cited By...
- No citing articles found.